This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Prognosis

Authoring team

The disease can either be self-limited or have a lifelong chronic course, but with treatment, about 50% of patients have marked improvement in visual field function. (1)

Treatment failure is associated with high-grade papilloedema, visual acuity loss, and frequent transient visual obscurations. (2)

References

  1. Wall M. Idiopathic intracranial hypertension. Neurol Clin. 2010 Aug;28(3):593-617.
  2. Wall M, Falardeau J, Fletcher WA, et al. Risk factors for poor visual outcome in patients with idiopathic intracranial hypertension. Neurology. 2015 Sep 1;85(9):799-805.

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.